Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

IMF to Redistribute U.S. Wealth

A global currency is in the works with those pursuing a One…
Read more

Rivlin Hands Netanyahu Mandate to Form Coalition

Netanyahu was mandated to build a coalition, so he has been…
Read more

Combat Surveillance Capitalism

Should there be laws in place to put a cap on how much data…
Read more